Doctor-Led AI Platform Offering 24x7 Monitoring Outside Hospital Launched in Chennai

Why It Matters

Continuous remote monitoring can reduce cardiac events, readmissions, and improve outcomes, addressing India's high heart‑disease burden.

Key Takeaways

• iLive Connect uses AI‑driven biosensor patch and wristband
• 40 doctors monitor patients 24/7 from remote command centre
• Early detection of subclinical cardiac issues in 1,000+ users
• Platform expands to chronic disease management and geriatric care
• Rollout planned across southern Indian states after Chennai launch

Pulse Analysis

India records roughly 8,000 heart‑related deaths each day, and up to 15,000 heart attacks occur daily, many without warning. This staggering cardiovascular load has pushed policymakers and clinicians to seek preventive solutions that move beyond the traditional symptom‑driven model. Remote patient monitoring, powered by artificial intelligence, has emerged as a viable strategy to capture early physiological signals and intervene before a crisis.

iLive Connect, the newly launched AI‑enabled ecosystem in Chennai, combines a lightweight biosensor patch with a wrist‑worn device to stream heart rhythm, blood pressure and other vitals in real time. An AI engine cleanses and flags anomalies, while a team of about 40 physicians at a central command centre reviews alerts around the clock. Early trials involving more than 1,000 participants have already identified subclinical arrhythmias and transient blood‑pressure spikes that routine office visits would miss, enabling timely medical advice and potentially averting acute events.

The platform’s roadmap includes expansion throughout southern India and integration with chronic‑disease pathways such as diabetes, hypertension, COPD and asthma. By extending continuous oversight into the vulnerable post‑discharge window, iLive Connect promises to lower readmission rates and associated costs for hospitals. Its doctor‑led, AI‑first approach signals a broader shift in the Indian healthcare market toward data‑driven, home‑based care, positioning the company to capture a growing tele‑health segment valued in the billions of dollars.